Replimune Group, Inc. — Director's Dealing 2018

Jul 26, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2018-07-24

Reporting Person: Astley-Sparke Philip (Director, Executive Chairman)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-24	Employee Stock Option (right to buy)	$15.00	A	140000	Acquired	2028-07-19	Common Stock (140000)	Direct

Footnotes

F1: This option was granted on July 19, 2018 subject to the completion of the Issuer's initial public offering, which closed on July 24, 2018. 25% of the shares underlying this stock option vest on July 19, 2019 and the remainder of the shares underlying this stock option vest in 36 equal monthly installments thereafter.